Proteomics

Dataset Information

0

Multiplexed Proteome Profiling of Targeted Protein Degradation With Data-Independent Acquisition-Based Mass Spectrometry


ABSTRACT: Targeted protein degradation (TPD) has become a powerful and promising tool that can effective trigger the degradation of specific disease-related proteins utilizing the endogenous pathways of the organism. However, the global proteomic profiling of TPD with multiple dimensions remains lacking since traditional methods of protein quantification are low-throughput and time-consuming. Mass spectrometry (MS)-based quantitative proteomics have been used in TPD research. The quantification with isobaric mass tagging has the problems such as preference for high-abundance species, high cost and ratio compression effects. Here, we employed data-independent acquisition (DIA) MS with multiplexed proteome profiling of TPD, termed DIA-MPT, to implement the label-free proteomic quantitation with satisfactory reproducibility and high accuracy. We demonstrated the power of DIA-MPT for comprehensive profiling of proteolysis targeting chimera (PROTAC) degraders of bromodomain and extra-terminal (BET) and signal transducer and activator of transcription 3 (STAT3) with pharmacodynamic response and drug sensitivity analysis. Consequently, DIA-MPT has potential as a new platform for high-throughput, flexible, and comprehensive multidimensional proteomic profiling of TPD.

ORGANISM(S): Homo Sapiens Mus Musculus

SUBMITTER: Hu Zhou  

PROVIDER: PXD050426 | iProX | Wed Mar 06 00:00:00 GMT 2024

REPOSITORIES: iProX

altmetric image

Publications

Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3.

Suo Yuying Y   Du Daohai D   Chen Chao C   Zhu Hongwen H   Wang Xiongjun X   Song Nixue N   Lu Dayun D   Yang Yaxi Y   Li Jiacheng J   Wang Jun J   Luo Zhongyuan Z   Zhou Bing B   Luo Cheng C   Zhou Hu H  

Journal of medicinal chemistry 20240311 6


Proteolysis-targeting chimera (PROTAC) is a powerful technology that can effectively trigger the degradation of target proteins. The intricate interplay among various factors leads to a heterogeneous drug response, bringing about significant challenges in comprehending drug mechanisms. Our study applied data-independent acquisition-based mass spectrometry to multidimensional proteome profiling of PROTAC (DIA-MPP) to uncover the efficacy and sensitivity of the PROTAC compound. We profiled the sig  ...[more]

Similar Datasets

2025-02-14 | PXD058918 | Pride
2024-10-14 | PXD052080 | Pride
| PRJNA854891 | ENA
2021-02-02 | PXD021922 | Pride
2023-04-19 | GSE215843 | GEO
2022-05-24 | GSE193196 | GEO
2022-05-24 | GSE193129 | GEO
2012-09-01 | E-GEOD-39025 | biostudies-arrayexpress
2021-12-16 | PXD024133 | Pride
2021-02-25 | PXD020828 | Pride